Posts tagged "OTCQB"

Penny Stock News: Destiny Media Technologies, Inc. (DSNY: OTCQB) | Destiny Media Technologies Schedules Fourth Quarter Fiscal 2016 Earnings Release and Conference Call

VANCOUVER, Nov. 25, 2016 /PRNewswire/ – Destiny Media Technologies (TSXV: DSY) (OTCQX: DSNY), the global standard for the secure distribution of pre-release music to radio and the developer of a new cross-platform playerless video streaming format, today announced that the Company will hold a conference call on Tuesday, November 29, 2016 at 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time) to discuss financial results for its fourth quarter ended August 31, 2016. The Company plans to release financial results for the quarter in a press release after the market closes on November 29, 2016. The conference call will include comments from President, Chief Executive Officer and Chairman, Steven Vestergaard, and Chief Financial Officer, Fred Vandenberg. Date: Tuesday, November 29, 2016Time: 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time)Direct dial in: 416-764-8688North America toll-free participant dial in: 888-390-0546Conference ID: 05294037 A replay of the call will be available until December 6, 2016. Direct replay: 416-764-8677North America toll-free replay: 888-390-0561Replay passcode: 294037# A replay will also be available on Destiny’s corporate site at http://www.dsny.com in the Company’s proprietary Clipstream® format. About Destiny Media Technologies, Inc.Destiny Media Technologies provides services that enable content owners to securely display and distribute their audio and […]

Read more...

Posted by admin - November 25, 2016 at 7:02 pm

Categories: Latest Penny Stock News   Tags: , , , , , , , , , , , , , , , , ,

Penny Stock News: Chesapeake Energy Corp. (CHKDP: OTCQB) | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Chesapeake Energy Corporation of Class Action Lawsuit and Upcoming Deadline – CHK

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Chesapeake Energy Corporation of Class Action Lawsuit and Upcoming Deadline – CHK Nov 25, 2016 OTC Disclosure & News Service – NEW YORK, Nov. 25, 2016 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Chesapeake Energy Corporation (“Chesapeake” or the “Company”) (NYSE:CHK) and certain of its officers.   The class action, filed in United States District Court, Western District of Oklahoma, and docketed under 16-cv-01150, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Chesapeake securities between February 27, 2015 and September 28, 2016 both dates inclusive (the “Class Period”).  This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).  If you are a shareholder who purchased Chesapeake securities during the Class Period, you have until December 5, 2016 to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com.   To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, […]

Read more...

Posted by admin - November 25, 2016 at 2:19 pm

Categories: Latest Penny Stock News   Tags: , , , , , , , , , , , , , , , , , , , , , ,

Penny Stock News: Marina Biotech, Inc. (MRNA: OTCQB) | Marina Biotech to Present at the 9th Annual LD Micro Main Event

BOTHELL, WA–(Marketwired – Nov 25, 2016) – Marina Biotech, Inc. (OTCQB: MRNA) today announced that its CEO, Joseph W. Ramelli, will be presenting at the LD Micro Main Event on Thursday, December 8, 2016 at 8am PT, at the Luxe Sunsent Boulevard Hotel in Los Angeles.  Management will update investors on the synergy derived from the recent merger with IthenaPharma to deliver unparalleled targeted therapy against colorectal cancer as well as familial adenomatous polyposis (FAP).  In addition, Mr. Ramelli and Marina Biotech’s chairman, Dr. Vuong Trieu, will participate in 1-on-1 meetings with conference attendees. A copy of the investor presentation will be accessible in the investor relations section of the company’s website at http://www.marinabio.com/investors/. About Marina Biotech, Inc. Marina Biotech is a clinical stage development and commercialization company, with a pipeline focused on treating familial adenomatous polyposis (FAP) and colon cancer. In addition, Marina has a preclinical program for myotonic dystrophy, using its own unique antisense oligonucleotide chemistry and delivery capabilities. Marina Biotech Forward-Looking Statements Statements made in this news release may be forward-looking statements within the meaning of Federal Securities laws that are subject to certain risks and uncertainties and involve factors that may cause actual results to differ materially […]

Read more...

Posted by admin - November 25, 2016 at 1:08 pm

Categories: Latest Penny Stock News   Tags: , , , , , , , , , , , ,

Penny Stock News: Hillcrest Petroleum Ltd. (HLRTF: OTCQB) | HILLCREST COMPLETES ONSHORE SALE OF TWO OFFSHORE PROPERTIES

HILLCREST COMPLETES ONSHORE SALE OF TWO OFFSHORE PROPERTIES Nov 24, 2016 OTC Disclosure & News Service Vancouver, BC, Canada This release includes additional documents. Select the link(s) below to view. 20161124 EI32_WC498 PR – Final.pdf Copyright © 2016 OTC Markets. All Rights Reserved The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases. OTC Markets Group – News, Filings & Corporate Actions

Read more...

Posted by admin - November 25, 2016 at 12:12 am

Categories: Latest Penny Stock News   Tags: , , , , , , , , , , , ,

Penny Stock News: Revive Therapeutics Ltd. (RVVTF: OTCQB) | Revive Therapeutics Ltd. Announces Results for the Three Months Ended September 30, 2016

TORONTO, ONTARIO–(Marketwired – Nov 24, 2016) – Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV)(OTCQB:RVVTF), a company focused on commercializing treatments for rare diseases such as Cystinuria, Wilson’s disease and Rett Syndrome, today announced its results for the three months ended September 30, 2016. The unaudited condensed interim consolidated financial statements and related interim management’s discussion and analysis for the three months ended September 30, 2016 may be viewed on SEDAR at www.sedar.com. Operational Highlights Subsequent to its three months ended on September 30, 2016, the Company announced that it has named Dr. David S. Goldfarb, MD, as Principal Investigator of Revive’s upcoming Phase 2 clinical study for Cystinuria. Financial Highlights Cash and cash equivalents at September 30, 2016 totaled $ 2,100,339 (June 30, 2016 – $ 1,333,239). The net loss for the three months ended September 30, 2016 was $ 357,704 (three months ended September 30, 2015 – $ 912,799). The Company’s research costs for the three months ended September 30, 2016 were $ 57,112 (three months ended September 30, 2015 – $ 653,732). About Revive Therapeutics Ltd. Revive Therapeutics Ltd. (TSX VENTURE:RVV)(OTCQB:RVVTF) is focused on commercializing treatments for rare diseases such as Cystinuria, Wilson’s disease and Rett […]

Read more...

Posted by admin - November 24, 2016 at 10:59 pm

Categories: Latest Penny Stock News   Tags: , , , , , , , , , , , , , ,

Penny Stock News: Aphria Inc. (APHQF: OTCQB) | CORRECTION – Aphria agrees with changes to Veteran Affairs policy

LEAMINGTON, ONTARIO–(Marketwired – Nov. 24, 2016) – In the news release, “Aphria agrees with changes to Veteran Affairs policy” issued earlier today by Aphria Inc. (TSX VENTURE:APH)(OTCQB:APHQF), please be advised that previous versions should be disregarded. They were issued incorrectly by Marketwired. Complete corrected text follows. Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) agrees with the recent changes made by the Canadian federal government to its Veteran Affairs policy on medical cannabis. The change limits the daily amount prescribed to veterans to three grams unless they receive a special exemption.  “We always fulfill patients’ orders based on the recommended dosage from their doctor, so we’re pleased that the new regulations include provisions for veterans individual requirements and that coverage will be tailored accordingly,” said Vic Neufeld, Chief Executive Officer. Aphria works in full transparency with Health Canada within strict regulatory guidelines and to the highest ethical standards when delivering health care options. The Company does not engage in the practice of dual pricing between veteran and non-veteran platforms. Aphria is committed to working with Health Canada and all regulators to ensure that all patients, regardless of medical coverage, continue to receive the best possible treatment options. The CannWay brand is an example […]

Read more...

Posted by admin - November 24, 2016 at 5:05 pm

Categories: Latest Penny Stock News   Tags: , , , , , , , , , , , ,

Penny Stock News: Aphria Inc. (APHQF: OTCQB) | CORRECTION – Aphria agrees with changes to Veteran Affairs policy

LEAMINGTON, ONTARIO–(Marketwired – Nov 24, 2016) – In the news release, “Aphria agrees with changes to Veteran Affairs policy” issued earlier today by Aphria Inc. (TSX VENTURE:APH)(OTCQB:APHQF), please be advised that previous versions should be disregarded. They were issued incorrectly by Marketwired. Complete corrected text follows. Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) agrees with the recent changes made by the Canadian federal government to its Veteran Affairs policy on medical cannabis. The change limits the daily amount prescribed to veterans to three grams unless they receive a special exemption. “We always fulfill patients’ orders based on the recommended dosage from their doctor, so we’re pleased that the new regulations include provisions for veterans individual requirements and that coverage will be tailored accordingly,” said Vic Neufeld, Chief Executive Officer. Aphria works in full transparency with Health Canada within strict regulatory guidelines and to the highest ethical standards when delivering health care options. The Company does not engage in the practice of dual pricing between veteran and non-veteran platforms. Aphria is committed to working with Health Canada and all regulators to ensure that all patients, regardless of medical coverage, continue to receive the best possible treatment options. The CannWay brand […]

Read more...

Posted by admin - November 24, 2016 at 3:53 pm

Categories: Latest Penny Stock News   Tags: , , , , , , , , , , , ,

Penny Stock News: Almost Never Films Inc. (HLWD: OTCQB) | Almost Never Films, Inc. Joins Forces with Two-Time Emmy Award Winning Konwiser Brothers Media to Produce Movie “Field Trip”

LOS ANGELES, Nov. 23, 2016  /PRNewswire/ — Almost Never Films, Inc. (OTCQB: HLWD), a publicly traded independent film company based in Los Angeles, California, is proud to announce their partnership with Konwiser Brothers Media (KBM) (http://www.konwiserbros.com) to develop and produce motion picture project “Field Trip”. Danny Chan, CEO of Almost Never Films, Inc. and Frank Gillen will serve as executive producers. Kip Konwiser and Kern Konwiser of Konwiser Brothers Media will be engaged as the lead producer, writer and director.  The Konwiser Brothers are industry leaders in writing, producing, directing and marketing award-winning theatrical films, documentaries, cable and network movies & series and other entertainment media.  Among their award-winning credits are the HBO film “Miss Evers’ Boys” (winner of 5 Emmy Awards, 3 NAACP Image Awards, The Humanitas Prize and the Producers Guild of America Producer of the Year Award) and the documentary “On Hallowed Ground” (winner of Sports Emmy Award for Best Documentary and winner of Gold Medal at New York Film Festival). KBM will contribute its development and producing services and Almost Never Films making financial contributions and participating in the development and production process.  “We’re excited to partner with Kip and Kern on this feature film. ‘Field […]

Read more...

Posted by admin - November 24, 2016 at 4:05 am

Categories: Latest Penny Stock News   Tags: , , , , , , , , , , , , , , , , , , , , ,

Penny Stock News: NuZee, Inc. (NUZE: OTCQB) | United Natural Foods, Inc. To Launch NuZee, Inc.’s Coffee Blenders® Line Nationwide

VISTA, Calif., Nov. 23, 2016 /PRNewswire/ — NuZee, Inc. (OTC: NUZE) (“NuZee” or “Coffee Blenders ®“) is pleased to announce today the launch of its revolutionary line of functional and organic coffee lines nationwide with United Natural Foods, Inc. (UNFI). Coffee Blenders will be featured in UNFI’s “New and Now” publication and the “New Products” section of the monthly special alongside their vast variety of all natural and organic products. UNFI selected our MATCHA CUP, ACTIVE CUP ®, LEAN CUP ®, THINK CUP ®, & RELAX CUP ® 2.0 single serve cups to launch in eight distribution centers throughout the nation. This will enable our brand to be available to order by an account base of 45,000+ natural and organic grocery retailers, both independents and regional chains across the United States. This new product launch with UNFI will strengthen Coffee Blenders’ points of distribution and help plant the seed for what we anticipate to be a vast network of stores that will stock our products on their grocery aisle shelves. Our products will now be available to customers on the West Coast, Midwest, East Coast and throughout the South. About Coffee Blenders:  NuZee, Inc. was founded in 2012 with the […]

Read more...

Posted by admin - November 24, 2016 at 12:33 am

Categories: Latest Penny Stock News   Tags: , , , , , , , , , , , , , , ,

Penny Stock News: Ener-Core, Inc. (ENCR: OTCQB) | Ener-Core to Participate at Upcoming Investor Conferences

The Drexel Hamilton Emerging Growth Conference on December 1 & the 9th Annual LD Micro Main Event on December 6 IRVINE, CA–(Marketwired – November 23, 2016) – Ener-Core, Inc. (OTCQB: ENCR), a developer of innovative gas conversion technologies for global commercial and industrial facilities, has been invited to participate at two upcoming investor conferences in December 2016. The Drexel Hamilton Emerging Growth Conference is being held on December 1, 2016 at the company’s corporate headquarters, 77 Water Street in New York City. Ener-Core CEO, Alain Castro is scheduled to present on Thursday, December 1st at 3:30 p.m. Eastern time with one-on-one meetings held throughout the conference. For additional information or to schedule a one-on-one meeting with Ener-Core management, please contact your Drexel Hamilton institutional sales representative or the company’s investor relations firm, MZ Group. The 9th Annual LD Micro Main Event is being held on December 6-8, 2016 at the Luxe Sunset Boulevard Hotel in Los Angeles. Ener-Core CEO, Alain Castro and CFO, Domonic Carney are scheduled to present on Tuesday, December 6th at 10:00 a.m. Pacific time with one-on-one meetings held throughout the conference. For additional information or to schedule a one-on-one meeting with Ener-Core management, please log-in via […]

Read more...

Posted by admin - November 23, 2016 at 10:11 pm

Categories: Latest Penny Stock News   Tags: , , , , , , , , , ,

Next Page »